Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
Telehealth ketamine in New Hampshire is legal for residents seeking treatment for conditions such as treatment-resistant depression, provided the prescriber follows New Hampshire Board of Medicine standards and federal controlled substance rules. New Hampshire's broad nurse practitioner scope of practice and telehealth-friendly statutes make it one of the more accessible states in New England for this type of care. Ketamine is a Schedule III controlled substance under federal law, so prescribers must complete a real-time evaluation and document a valid provider-patient relationship before prescribing. Because telehealth and controlled substance rules continue to change at the state and federal level, confirm current requirements before scheduling an appointment.
Quick Answer
Telehealth ketamine in New Hampshire is legal under the federal Ryan Haight Act and the state's telehealth statute, RSA 329:1-d. Physicians, nurse practitioners with full practice authority, and in some cases physician assistants can prescribe ketamine after a real-time video evaluation. Most private insurance and New Hampshire Medicaid do not cover off-label ketamine, though Spravato (esketamine) may be covered with prior authorization for treatment-resistant depression. No additional state-specific in-person visit is currently required beyond federal DEA expectations, but verify this with the New Hampshire Board of Medicine before assuming a fully remote pathway.
Is Telehealth Ketamine Legal in New Hampshire?
Yes. New Hampshire regulates telehealth practice under RSA 329:1-d, which allows licensed physicians to establish a valid provider-patient relationship and prescribe medication, including controlled substances, through telehealth technology. Because ketamine is a Schedule III controlled substance, prescribers must also follow the federal Ryan Haight Online Pharmacy Consumer Protection Act, which sets baseline requirements for prescribing controlled substances through telehealth. The New Hampshire Board of Medicine oversees physician licensing and practice standards, and the state's membership in the Interstate Medical Licensure Compact makes it easier for out-of-state physicians to obtain a New Hampshire license and treat residents remotely. Any provider treating a patient physically located in New Hampshire must hold a New Hampshire license, regardless of where the provider is based. For the general process of starting care, see our guide on how to get a ketamine prescription online.
Who Can Prescribe Ketamine via Telehealth in New Hampshire?
New Hampshire grants nurse practitioners full practice authority, which includes independent prescribing of Schedule III controlled substances like ketamine without physician oversight. This means a telehealth ketamine visit may be conducted by a physician, a nurse practitioner, or, depending on supervision agreements, a physician assistant. Patients can confirm a prescriber's license status and scope of practice directly with the New Hampshire Board of Medicine or the New Hampshire Board of Nursing before starting treatment.
Do You Need an In-Person Visit Before Starting Telehealth Ketamine?
Not necessarily. Federal DEA flexibilities first extended during the COVID-19 public health emergency continue to allow many telehealth evaluations for controlled substances without a prior in-person exam, though this remains subject to ongoing federal rulemaking. New Hampshire does not layer an additional state-specific in-person requirement on top of federal expectations. Because federal telehealth prescribing rules for controlled substances have shifted multiple times in recent years, ask your provider directly whether an in-person visit applies to your case, and see our telehealth legality overview for the federal rules that apply across states.
Provider Availability and Compounding Pharmacy Access
Provider availability for telehealth ketamine in New Hampshire is moderate to high, helped by the state's proximity to Boston-area medical centers and its Interstate Medical Licensure Compact membership. Patients in Nashua, Manchester, and Concord generally have the most local options, while residents of Coos County and the Lakes Region rely more heavily on telehealth to reach ketamine-specific expertise. Compounding pharmacies serving New Hampshire operate under New Hampshire Board of Pharmacy oversight and must meet USP compounding standards; patients can also receive shipments from properly licensed out-of-state pharmacies in Massachusetts and elsewhere in New England, typically with short delivery times. Our provider selection guide outlines questions to ask before choosing a telehealth ketamine provider.
Compare your options
Move from the guide into a side-by-side comparison when you are ready to evaluate tradeoffs.
Compare optionsAdvantages
- Broad nurse practitioner prescribing authority reduces reliance on psychiatrist availability
- Interstate Medical Licensure Compact membership brings in more out-of-state providers
- Short shipping distances from regional compounding pharmacies in New England
- No added state-specific in-person visit requirement beyond federal rules
Considerations
- Most private insurance and New Hampshire Medicaid do not cover off-label ketamine
- Specialist availability is thinner in Coos and Grafton counties
- Winter storms can delay medication shipments
- Federal telehealth prescribing rules for controlled substances remain subject to change
Insurance and Cost Considerations
Insurance coverage for off-label ketamine therapy is limited in New Hampshire, consistent with national trends. Most private health plans and New Hampshire Medicaid do not cover compounded oral, sublingual, or IM ketamine used off-label for depression or anxiety. Spravato (esketamine), the FDA-approved nasal spray for treatment-resistant depression, is more likely to be covered by commercial insurance or New Hampshire Medicaid when prior authorization criteria are met. Telehealth ketamine consultations in New Hampshire generally run $200-$500 for an initial visit, with ongoing monthly costs of $100-$300 for medication and follow-up care. See our insurance versus cash-pay guide for how to check your specific plan.
Action Checklist for New Hampshire Patients
- Confirm your prescriber holds a valid New Hampshire medical or nursing license, even if the practice is based out of state
- Order refills early in winter months in case nor'easters delay shipping
- Identify a support person who can be present during dosing sessions
- Ask your provider what screening and monitoring process they use before approving treatment
- Contact your insurance plan directly to ask about Spravato prior authorization or mental health parity coverage for telehealth visits
Important
Telehealth and controlled substance rules for ketamine continue to evolve at both the state and federal level. Confirm current requirements with the New Hampshire Board of Medicine before assuming a specific pathway, such as a fully remote evaluation, is available to you.
Learn More
See what a telehealth ketamine evaluation involves and whether it may fit your care plan in New Hampshire.
Frequently Asked Questions
Yes. Ketamine is a Schedule III controlled substance that any licensed prescriber in New Hampshire can prescribe off-label when clinically appropriate, whether through telehealth or an in-person visit.
Yes, as long as the provider holds a New Hampshire license or one issued through the Interstate Medical Licensure Compact. The provider must be licensed in the state where you are physically located during the visit, not just where they are based.
The DEA has extended and adjusted its telehealth flexibilities for controlled substances several times since 2020. If federal rules tighten, some New Hampshire patients could be asked to complete an in-person evaluation before continuing treatment. Check with your provider or the New Hampshire Board of Medicine for the latest requirements.
New Hampshire does not have a specific state law requiring this, but most telehealth ketamine providers require a responsible adult to be present as a standard safety practice, particularly for sublingual or IM dosing at home.
Share
Related Reading
Have a question about this topic?
Use the contact page when you need to send feedback, request a correction, or ask about the resource.